Needle-exchange attendance and health care utilization promote entry into detoxification

Journal of Urban Health

Volumn 76, Issue 4, 1999, Pages 448-460

  Strath Dee, Steffanie A ^a   Celentano, David D ^a   Shah, Nina ^b   Lyles, Cynthia ^a   Stambolis, Veronica A ^b   Macalino, Grace ^b   Nelson, Kenrad ^b   Vlahov, David ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

Author keywords

Detoxification; HIV AIDS; Injection drug use; Needle exchange Programs; Substance abuse treatment

Indexed keywords

METHADONE;

ARTICLE; DETOXIFICATION; DRUG ABUSE; DRUG USE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEALTH PROGRAM; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PRIORITY JOURNAL;

EID: 0032734207     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02351502     Document Type: Article

References (27)

1. Lurie P, Reingold A, Bower B, et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. Vol 1. Atlanta, GA: Centers for Disease Control and Prevention; 1993.
2. Strathdee SA, van Ameijden E, Mesquita F, et al. Can HIV epidemics among injection drug users be prevented? AIDS. 1998;12(suppl A):S71-S79.
3. Normand J, Vlahov D, Moses LE. Preventing HIV Transmission: the Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995.
4. Hurley S, Jolley D, Kaldor J. Effectiveness of needle-exchange programmes for prevention of H1V infection. Lancet. 1997;349:1797-1800.
5. Paone D, Clark J, Shi Qiuhu, et al. Syringe exchange in the United States, 1996: a national profile. Am ] Public Health. 1999;89(l):43-46.
6. Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment? / Subst Abuse Treat. 1998;15(3):183-191.
7. Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high-risk drug use behaviours among participants in the Baltimore needle exchange program. / Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:400-406.
8. Heimer R, Kaplan EH, O'Keefe E, et al. Three years of needle exchange in New Haven: what have we learned? AIDS Public Policy }. 1994:9:59-74.
9. Brooner R, KidorfM, King V, Beilenson P, Svikis D, Vlahov D. Drug abuse treatment success among needle exchange participants. Public Health Rep. 1998;113(suppl 1):129-139.
10. Metzger DS, Navaline H, Woody GE. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998;113(1):97-105.
11. Centers for Disease Control and Prevention (US). Risk behaviors for HIV transmission among intravenous drug users not in treatment-United States. MMWR Morb Mortal Witty Rep. 199039:273-276.
12. Schuster CR. Intravenous drug use and HIV prevention. Public Health Rep. 1988;103: 261-263.
13. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. / Drug Issues. 1991; 21(4):759-776.
14. Anthony JC. Vlahov D, Nelson KE. New evidence on intravenous cocaine use and the risk of infection with human immunodeficiency virus type 1. Am J Epidemiol. 1991;134: 1175-1189.
15. Zeger S, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130.
16. Department of Health and Human Service, Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies. National Admissions to Substance Abuse Treatment Services, the Treatment Episode Data Set (TEDS) 1992-1996. Rockville, MD: Office of Applied Science; 1997.
17. Alcohol and Drug Abuse Administration. Trends and Patterns in Maryland Alcohol and Drug Abuse Treatment 1997. Baltimore, MD: Maryland Department of Health and Mental Hygiene; 1998.
18. Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe use and re-use: effects of syringe exchange programs in four cities. / Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):S37-S44.
19. Schlechter MT, Strathdee SA, Cornelisse PGA, et al. Do needle exchange programs increase the spread of HIV among injection drug users: an investigation of the Vancouver outbreak. AIDS. 1999;13:F45-F51.
20. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Science, Drug Abuse Network (DAWN) Series. D-3, Year-End Preliminary Estimates from the 1996 Drug Abuse Warning Network. Rockville, MD: Office of Applied Science; 1997.
21. CESAR. Heroin Related Emergency Report Visits in Baltimore Metro Area Highest Among Cities in DAWN System. Baltimore, MD: Drug Awareness Warning Network; 1995. Advance Report Number 11.
22. Lewin VHI, Inc. An Analysis of Pilot Data on the Cost of Substance Abuse Treatment: Unit Costs From 77 Service Delivery Units. Technical Report to the Center for Substance Abuse Treatment. Fairfax, VA: National Evaluation Data and Technical Assistance Center (NEDTAC); 1996.
23. Shutz CG, Rapiti E, Vlahov D, et al. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend. 1994-6:129-138.
24. Latkin C, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993;88:517-526.
25. De Irala J, Bigelow C, McCusker J, et al. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. Am J Epidemiol. 1996;143:725-731.
26. Graeven DB, Graeven KA. Treated and untreated addicts: factors associated with participation in treatment and cessation of heroin use. / Drug Issues. 1983;83(2):207-218.
27. McCusker J, Bigelow C, Luippold R, et al. Outcomes of a 21-day drug detoxification program: retention, transfer to further treatment, and HIV risk reduction. Am ] Drug Alcohol Abuse. 1995;21(1):1-16.